[pip08456]

A study by the University of Oxford, released in Cell, demonstrates that currently available vaccines, including AstraZeneca’s COVID-19 vaccine, will provide protection against the Delta (B.1.617.2) and Kappa (B1.617.1) variants; formerly the ‘Indian’ variants. The study investigated the ability of monoclonal antibodies in sera from recovered people, and sera from vaccinated people to neutralise the Delta and Kappa variants...

...These results build on the recent analysis by Public Health England showing early evidence of real-world data that two doses of AstraZeneca’s COVID-19 vaccine are effective against the Delta variant, with similar levels of protection achieved as those seen against the Alpha variant.

https://www.astrazeneca.com/media-ce...v-2-virus.html